Core Viewpoint - Huakong Kantech (01312.HK) expects significant financial losses due to anticipated impairment losses across various segments, leading to a projected net loss for the upcoming period [1] Financial Performance - The company anticipates financial asset impairment losses between approximately HKD 154.2 million and HKD 185.3 million [1] - Expected impairment losses for intangible assets are projected to be between approximately HKD 112.6 million and HKD 123.9 million [1] - The goodwill impairment loss for the fitness business segment is estimated to be between approximately HKD 80.4 million and HKD 88.8 million [1] Overall Impact - Due to the aforementioned expected impairment losses and a decline in revenue and gross profit in the pharmaceutical segment caused by intensified market competition, the company projects a consolidated net loss between approximately HKD 282.8 million and HKD 345.6 million for the period, compared to a consolidated net loss of approximately HKD 4.5 million in the same period last year [1]
华控康泰(01312.HK)预期中期亏损约2.83亿至3.456亿港元